Evidence map›Paper›PMID 35410822›Full record

ArticleThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation2022

Recovery of left ventricular function is associated with improved outcomes in LVAD recipients.

Cameron Olsen, Aditya Mandawat, Jie-Lena Sun, Taylor Triana, Karen Chiswell, Ravi Karra

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Mechanisms and Therapeutic Potential of Human Cardiomyocyte Proliferation.Journal of cardiovascular development and disease · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Article
  8. Does cardiac recovery favorably impact adverse events and outcomes of LVAD patients?The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Cameron OlsenDivision of Cardiology, Department of Medicine, Duke University, Durham, North Carolina.
Aditya MandawatChattanooga Heart Institute, Chattanooga, Tennessee.
Jie-Lena SunDuke Clinical Research Institute, Duke University, Durham, North Carolina.
Taylor TrianaDivision of Cardiology, Department of Medicine, Duke University, Durham, North Carolina.
Karen ChiswellDuke Clinical Research Institute, Duke University, Durham, North Carolina.
Ravi KarraDivision of Cardiology, Department of Medicine, Duke University, Durham, North Carolina; Department of Pathology, Duke University, Durham, North Carolina; Center for Aging, Duke University, Durham, North Carolina; Regeneration Next, Duke University, Durham, North Carolina. Electronic address: ravi.karra@duke.edu.
Duke University · USChattanooga Eye Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe significance of recovered left ventricular ejection fraction (LVEF) in LVAD recipients, outside of pump explantation, is unclear.

methodsPatients undergoing first LVAD implantation at Duke University Hospital between 2006 and 2017 were evaluated for LVEF recovery up to 2 years following implant. Occurrence of gastrointestinal bleeding (GIB), hospitalization for heart failure (HF), pump thrombosis and death were assessed before and after LVEF recovery.

resultsOf 286 patients who met inclusion criteria, 9.8% reached a "threshold" of recovery with an LVEF ≥ 40%. 17.4% achieved "relative" recovery with an increase in LVEF ≥ 10% since LVAD implantation. For either definition, recovered patients had a lower incidence of a composite endpoint of GIB, HF hospitalization, pump thrombosis, or death compared to patients without recovery. Patients with "threshold" recovery had 4.7 events per 100 patient-years (95% CI, 0.7-33.6) compared to 48.8 events per 100 patient-years (95% CI, 39.5-60.3) without "threshold" recovery [p = .020]. Those with "relative" recovery had 14.1 events per 100 patient-years [95% CI, 5.9-33.8] versus 50.7 events per 100 patient-years (95% CI, 40.7-63.0) without "relative" recovery [p = 0.005]. However, improved outcomes in the "relative" recovery group were limited to those who also met the "threshold" definition. Importantly, among patients who achieved "threshold" recovery, the incidence of the composite endpoint declines in the postrecovery period, suggesting that LVEF recovery mechanistically results in improved outcomes.

conclusionsAn LVEF ≥ 40% associates with better outcomes in LVAD recipients. Methods to promote recovery could reduce morbidity and mortality related to LVAD support.

Indexed as

Heart-Assist DevicesVentricular Function, LeftHumansRecovery of FunctionStroke VolumeTreatment Outcomegastrointestinal bleedingheart failureLVADrecovery

Identifiers

PMID35410822
OpenAlexW4220700489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.